ECM
BIO icon

EII Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

EII Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,150
Closed -$2.17M – 156
2014
Q3 		$2.17M Sell
19,150
-10,150
-35% -$1.2M 0.14% 70
2014
Q2 		$3.51M Buy
29,300
+150
+0.5% +$18.3K 0.07% 51
2014
Q1 		$3.73M Sell
29,150
-600
-2% -$76.9K 0.08% 50
2013
Q4 		$3.68M Buy
29,750
+3,000
+11% +$366K 0.09% 50
2013
Q3 		$3.15M Hold
26,750
– – 0.08% 51
2013
Q2 		$3M Buy
+26,750
New +$3.14M 0.07% 52

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EII Capital Management's BIO Position: Q4 2014 in Review

EII Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2014, closing a stake of 19,150 shares — an estimated $2.17M sold.

EII Capital Management first reported a position in BIO in Q2 2013 and held it in 6 quarters. The position peaked at $3.73M in Q1 2014. 216 funds tracked by Wall St. Rank hold BIO as of Q4 2014.

  • EII Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2014 after selling out during the quarter.
  • EII Capital Management sold 19,150 Bio-Rad Laboratories Class A shares in Q4 2014, an estimated $2.17M.
  • EII Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 6 quarters.
  • EII Capital Management's Bio-Rad Laboratories Class A position peaked at $3.73M in Q1 2014.
  • 216 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2014.

Based on EII Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.